糖尿病与高血压和心血管疾病相关性的研究进展

1. Molitch ME.Fujimoto W.Hamman RF The Diabetes Prevention Program and Its Global Implications 2003(90002)
2. Sowers JR.Epstein M.Frohlich ED Diabetes Hypertension and Cardiovascular Disease 2001(4)
3. Gress TW.Nieto FJ.Shahar E Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus:Atherosclerosis Risk in Communities Study 2000(13)
4. Golden SH.Wang NY.Klag M J Blood Pressure in Young Adulthood and the Risk of Type 2 Diabetes in Middle Age 2003(4)
5. Sowers JR.Reed J Clinical advisory treatment of hypertension in diabetes 2000
6. Lindholm LH The outcome of STOP-Hypertension-2 in relation to the 1999 WHO/ISH hypertension guidelines 2000
7. Hansson L.Lindholm LH.Niskanen L Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project(CAPPP) randomised trial 1999
8. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients 2000(3)
9. UK Prospective Diabetes Study Group Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 1998
10. Sowers JR.Bakris GL Antihypertensive therapy and the risk of type 2diabetes mellitus 2000(13)
11. Beckman JA.Creager MA.Libby P Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management 2002
12. Fogari R.Zoppi A.Corradi L ACE inhibition but not angiotensin Ⅱ antagonism reduced fibrinogen and insulin resistance in overweight hypertensive patients 1998(4)
13. Heart Outcomes Prevention Evaluation (HOPE) Study Effects of ramipril on cardiovascular and microvascular outcomes in peoples with diabetes mellitus: results of the HOPE study and MICROHOPE substudy 2000
14. Caldiz CI.Cingolani GE Insulin resistance in adipocytes from spontaneously hypertensive rats:effect of long-term treatment with enalapril and losartan 1999(8)
15. Rosner MH.Okusa MD Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus 2003
16. Tuomilehto J.Rastenyte D.Birkenhager WH Trial Investigators.Effects of calcium channel blockers in older patients with diabetes and systolic hypertension 1999(9)
17. Sowers JR Comorbidity of hypertension and diabetes: the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) 1998(9B)
18. Mancia G.Brown M.Castaigne A Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT) 2003(3)
19. Bloomgarden ZT.Obesity Hypertension,and Insulin Resistance 2002(11)
20. Haffner SM.Lehto S.Ronnemma T Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without myocardial infarction 1998(4)
21. Taal MW.Brenner BM Renoprotective benefits of RAS inhibition:from ACEI to angiotensin Ⅱ antagonists 2000(5)

更多...

1. 孙新宇 芪玄益心胶囊治疗糖尿病性冠心病的药效学实验及机制研究 [学位论文] 博士2005

更多...